NICGHD will employ a genomics approach, collecting and analyzing genetic, clinical, lifestyle and socio-economic data to study a range of clinical conditions that have puzzled and troubled public health experts for decades. The trans-NIH center will be directed by internationally renowned genetic epidemiologist Charles N. Rotimi, Ph.D., former director of the National Human Genome Center at Howard University.

"This new center will be an NIH resource to help move research related to the complex factors underlying health disparities into the 21 st century," said NIH Director Elias A. Zerhouni, M.D. "Synergy among the center's genetic and genomic researchers and disease experts in existing NIH research programs will advance our understanding of health disparities for the benefit of minority groups and all Americans."

" The priority of our center will be to understand how we can use the tools of genomics to address some of the issues we see with health disparities," Rotimi said. "The availability of tremendous expertise and the remarkable research infrastructure at NIH will make our research activities more robust and will allow us to tackle questions in ways that were not feasible in the past."

Genomic research has established that the genomes of any two individuals are very similar. However, the subtle genomic differences that remain contribute to unique biological traits, such as hair and eye color, as well as to the susceptibility to diseases and individual responses to drugs. Additional factors contribute to health and disease, including diet, exercise routines and access to medical care. Genetic epidemiologists study genetic differences in combination with environmental factors to assess disease susceptibility and resistance among individuals and population groups.

NICGHD will be established within the NIH Office of Intramural Research and administered by the National Human Genome Research Institute (NHGRI). Additional support for the center will come from the NIH Office of the Director, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Center for Information Technology. The research activities of NICGHD will take place on the NIH Bethesda campus.

Building upon his previous research, Rotimi will continue efforts to develop genetic epidemiology models and population-genetics research projects that provide insights about the interrelationships of culture, lifestyle, genetics, genomics and health. His research explores patterns and determinants of common complex diseases that affect populations both living in Africa today and those that are part of the African diaspora.

Rotimi, who also has been appointed senior investigator in the Inherited Disease Research Branch in NHGRI's Division of Intramural Research, has been extensively involved in a number of genetic epidemiology projects that are being conducted in several African countries, China and in the United States. These projects have included the Africa America Diabetes Mellitus study; the Howard University Family Study; the Genetics of Obesity in Blacks Study; the Black Women Health Study; Consent in Genetic Research: An International Trial; the Engagement of African Communities for the International HapMap Project; and the Genetic Basis of Podoconiosis, a foot-disfiguring disease impacting some who work barefoot in volcanic soils. These efforts have provided him the necessary expertise for assuming the directorship of NICGHD.

An additional focus of NICGHD will be to provide training opportunities for students and established scientists from developing countries and from minority groups in the United States.

Rotimi, who was born in Nigeria, received a B.S. from the University of Benin, Nigeria and an M.S. from the University of Mississippi in Oxford, Miss. He went on to earn an M.P.H. and Ph.D. from the University of Alabama at Birmingham. He is the founding and current president of the African Society of Human Genetics, whose membership is interested in using genomic tools to impact health for African people and the global community.

nih/

Tag Cloud

Order Adalat Without Prescription
Order Aldactone Without Prescription
Order Altace Without Prescription
Order Atenolol Without Prescription
Order Avalide Without Prescription
Order Avapro Without Prescription
Order Azor Without Prescription
Order Benicar Without Prescription
Order Betapace Without Prescription
Order Caduet Without Prescription
Order Captopril Without Prescription
Order Cardura Without Prescription
Order Clonidine Without Prescription
Order Co-Diovan Without Prescription
Order Cordarone Without Prescription
Order Coreg Without Prescription
Order Coversyl Without Prescription
Order Cozaar Without Prescription
Order Diltiazem HCL Without Prescription
Order Diovan Without Prescription
Order Hydrochlorothiazide Without Prescription
Order Hytrin Without Prescription
Order Hyzaar Without Prescription
Order Inderal Without Prescription
Order Isosorbide Mononitrate Without Prescription
Order Lanoxin Without Prescription
Order Lasix Without Prescription
Order Lipitor Without Prescription
Order Lotensin Without Prescription
Order Lotrel Without Prescription
Order Lozol Without Prescription
Order Micardis Without Prescription
Order Minipress Without Prescription
Order Nebivolol Without Prescription
Order Norvasc Without Prescription
Order Plavix Without Prescription
Order Pletal Without Prescription
Order Prinivil Without Prescription
Order Rosulip-F Without Prescription
Order Toprol XL Without Prescription
Order Torsemide Without Prescription
Order Trandate Without Prescription
Order Trental Without Prescription
Order Triamterene Without Prescription
Order Tricor Without Prescription
Order Vasotec Without Prescription
Order Vastarel Without Prescription
Order Verapamil Without Prescription
Order Zebeta Without Prescription
Order Zestoretic Without Prescription